Lyell Competitors and Similar CompaniesClear all

Jounce Therapeutics's competitors and similar companies include NovoCure and Agenus.
Jounce Therapeutics
Jounce Therapeutics
Jounce Therapeutics is a clinical-stage immunotherapy company.
NovoCure
NovoCure
NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Agenus
Agenus
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
Founding Date
Founding Date
2013
Founding Date
2000
Founding Date
1994
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Saint Helier, JE HQ
München, DE
Haifa, IL
Tokyo, JP
Root, CH
Malvern, US
New York, US
see more
Locations
Lexington, US HQ
Cambridge, GB
Emeryville, US
Berkeley, US
Vacaville, US
Employees
Employees
1302% increase
Employees
1,488
Employees
8174% decrease
Valuation ($)
Valuation ($)
101.6 m
Valuation ($)
1.8 b
Valuation ($)
96.2 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$655.4m (FY, 2025)
Revenue (est.)
$114.2m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$166.9m (FY, 2025)
Cost of goods
$1m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
$488.5m (FY, 2025)
Gross profit
$113.2m (FY, 2025)
Net income
Net income
($50.9m) (FY, 2022)
Net income
($136.2m) (FY, 2025)
Net income
($3.1m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 103m
Total funding raised
N/A
Total funding raised
$ 171.1m
For sources of this data, please see the company profile

View Company Profiles

NovoCure
HQ
Saint Helier, JE
Employees
1,488

NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.

View company
Agenus
HQ
Lexington, US
Employees
81

Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.

View company